Executives On The Move: Alnylam Decides On Next CFO, Annexon Picks A CBO And Eli Lilly Announces A New Area President
Executive Summary
At Alnylam a new CFO is in place. Annexon Biosciences chooses as CBO a Johnson & Johnson Innovation leader and Eli Lilly & Co promotes exec to SVP and President, Lilly Bio-Medicines.